Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Adipokines as potential prognostic biomarkers in patients with acute knee injury

Kluzek S., Arden NK., Newton J.

Narrative Review on Knee Osteoarthritis, Osteoarthritis, published in Biomarkers (2015) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Biomarkers (2015)
Reported sample size
—
Source database
Europe PMC
PMID
26006054
PMCID
PMC4819580
DOI
10.3109/1354750x.2014.948914
Citations
14

Abstract (original English)

This review considers adipokines as predictive biomarkers for early onset post-traumatic knee osteoarthritis (KOA). Serum concentrations of leptin and resistin can predict radiographic changes and are elevated in early KOA, with higher leptin concentrations independently associated with more severe knee changes. Plasma concentrations of resistin are chronically elevated after injury. Leptin, resistin, chemerin and vistfatin induce catabolic enzymes associated with cartilage degeneration. Available literature on adipokines in post-traumatic KOA pathogenesis suggests that they could contribute to risk prediction of early onset post-traumatic KOA. Further research is needed to further understand the association between adipokines, synovitis and long-term outcomes in this population.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Cartilage, ArticularBone and BonesSynovial MembraneKnee JointAnimalsHumansOsteoarthritis, KneeKnee InjuriesAcute DiseaseEarly Diagnosis

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research